title: Coping with vaccine manufacturing delays.
abstract: With production of influenza vaccine delayed this year, physicians must prioritize and vaccinate those at highest risk first. Antiviral drugs can reduce the duration of symptoms by 1 to 2 days but should not be the first-line strategy for prevention.
authors: Department of General Internal Medicine, Cleveland Clinic Foundation, OH 44195, USA. nielsec@ccf.org
authors: C
authors: C
authors: Nielsen
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D002487:Centers for Disease Control and Prevention, U.S.; D017408:Guidelines as Topic; D006297:Health Services Accessibility / Q000458:organization & administration; D006801:Humans; D017589:Immunization Programs / Q000379:methods; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control*; D008875:Middle Aged; D013997:Time Factors; D014481:United States; D014612:Vaccines / Q000008:administration & dosage* / Q000600:supply & distribution
chemical_list: D000998:Antiviral Agents; D014612:Vaccines